The opioid crisis in 2023, amid the Biden administration, cost the U.S. $2.7 trillion, according to a Council of Economic ...

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

A Maryland mom got diagnosed with a condition she didn’t know she had. Then she couldn’t afford the medicine. Now, state ...

Under the leadership of Democratic Gov. Tina Kotek and House Democratic leaders, the state has pumped money into increasing Oregonians’ access to mental health care and addiction treatment. Most ...

Gov. Ned Lamont eyed Medicaid reimbursement rates, a hospital tax restructuring and pharmaceutical costs in his biennial ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

These medications are life and death for someone coming out of custody and in that state,” said Mary Taylor, a clinical ...

Abrupt changes to programmes including USAID inhibit global efforts to stop disease such as HIV, malaria and more, say ...

The 340B Drug Pricing Program allows certain hospitals and clinics to buy medications given to outpatients at a discount, ...

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

President Donald Trump's steep tariffs on Canada, Mexico and China could worsen exist­ing drug short­ages in the U.S. and ...